Pharmadrug Inc. LMLLF OTC

Pharmadrug Inc. (LMLLF) generated $-73.00 in operating cash flow for quarter ending 2025-06-30. After capital expenditures of $0.00, free cash flow was $-73.00.

Cash conversion ratio was 0x, suggesting some earnings are non-cash.

Criteria supported by this page:

• HEALTH (0/100, Fail) — weak cash flow raises concerns about debt servicing
• MOAT (11/100, Fail) — limited free cash flow weakens the competitive position
• INCOME (?/100) — Cash conversion ratio was 0x suggests some earnings are non-cash items

Overall SharesGrow Score: 6/100 with 0/7 criteria passed.